Patrice A. Lee

1.6k total citations
17 papers, 1.1k citations indexed

About

Patrice A. Lee is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Patrice A. Lee has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Patrice A. Lee's work include Melanoma and MAPK Pathways (3 papers), Nuclear Structure and Function (3 papers) and Cancer Mechanisms and Therapy (2 papers). Patrice A. Lee is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Nuclear Structure and Function (3 papers) and Cancer Mechanisms and Therapy (2 papers). Patrice A. Lee collaborates with scholars based in United States and Belgium. Patrice A. Lee's co-authors include James R. Matson, Thierry Dugernier, Patrick M. Honoré, B. Pirenne, J. Jamez, Kevin M. Koch, James D. Winkler, Eli Wallace, Tammie C. Yeh and Stefan Groß and has published in prestigious journals such as Circulation, Blood and Hepatology.

In The Last Decade

Patrice A. Lee

17 papers receiving 1.1k citations

Peers

Patrice A. Lee
Elin Mortensen Norway
Henrik Einwächter Germany
Zibo Meng China
Masaki Mizumoto Japan
Marek Nowak Poland
Nancy A. Turner United States
Stefan Liebe Germany
Thomas Robert France
Elena Magni Italy
Jun Xue China
Elin Mortensen Norway
Patrice A. Lee
Citations per year, relative to Patrice A. Lee Patrice A. Lee (= 1×) peers Elin Mortensen

Countries citing papers authored by Patrice A. Lee

Since Specialization
Citations

This map shows the geographic impact of Patrice A. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice A. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice A. Lee more than expected).

Fields of papers citing papers by Patrice A. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrice A. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice A. Lee. The network helps show where Patrice A. Lee may publish in the future.

Co-authorship network of co-authors of Patrice A. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Patrice A. Lee. A scholar is included among the top collaborators of Patrice A. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice A. Lee. Patrice A. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Judge, Daniel P., Matthew R.G. Taylor, Hui‐Hua Li, et al.. (2023). Long-Term Effectiveness of ARRY-371797 in People With Dilated Cardiomyopathy and a Faulty LMNA Gene: A Plain Language Summary. Future Cardiology. 19(3). 117–126. 2 indexed citations
2.
MacRae, Calum A., Matthew R.G. Taylor, Luisa Mestroni, et al.. (2022). Efficacy and Safety of ARRY-371797 in LMNA -Related Dilated Cardiomyopathy: A Phase 2 Study. Circulation Genomic and Precision Medicine. 16(1). e003730–e003730. 12 indexed citations
3.
Judge, Daniel P., Neal K. Lakdawala, Matthew R.G. Taylor, et al.. (2021). Abstract 12210: Long-Term Efficacy and Safety of ARRY-371797 (PF-0765803) in an Open-Label Rollover Study in Patients With Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation. Circulation. 144(Suppl_1). 2 indexed citations
4.
Hinklin, Ronald J., Brian R. Baer, Steven A. Boyd, et al.. (2019). Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator. Bioorganic & Medicinal Chemistry. 28(1). 115232–115232. 10 indexed citations
5.
Hinklin, Ronald J., Steven A. Boyd, Mark J. Chicarelli, et al.. (2013). Identification of a New Class of Glucokinase Activators through Structure-Based Design. Journal of Medicinal Chemistry. 56(19). 7669–7678. 26 indexed citations
6.
Anderson, Deborah, et al.. (2012). Abstract 852: ARRY-380, a potent, small molecule inhibitor of ErbB2, increases survival in intracranial ErbB2+ xenograft models in mice. Cancer Research. 72(8_Supplement). 852–852. 32 indexed citations
7.
Bouhana, Karyn, Richard Woessner, Ira von Carlowitz, et al.. (2012). Abstract 1798: Identification of pan-Trk inhibitors for the treatment of Trk-driven cancers. Cancer Research. 72(8_Supplement). 1798–1798. 1 indexed citations
8.
Woessner, Richard, Shannon L. Winski, Sumeet Rana, et al.. (2010). Abstract 2514: ARRY-162, A Potent and Selective MEK 1/2 Inhibitor, Shows Enhanced Efficacy in Combination with Other Targeted Kinase Inhibitors and with Chemotherapy. Cancer Research. 70(8_Supplement). 2514–2514. 4 indexed citations
9.
Lee, Patrice A., Eli Wallace, Allison Marlow, et al.. (2010). Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor. Cancer Research. 70(8_Supplement). 2515–2515. 28 indexed citations
10.
11.
Yeh, Tammie C., Vivienne Marsh, Bryan A. Bernat, et al.. (2007). Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor. Clinical Cancer Research. 13(5). 1576–1583. 442 indexed citations
12.
Lee, Patrice A., Lawrence M. Blatt, Karin S. Blanchard, et al.. (2000). Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice. Hepatology. 32(3). 640–646. 38 indexed citations
13.
Honoré, Patrick M., J. Jamez, Patrice A. Lee, et al.. (2000). Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Critical Care Medicine. 28(11). 3581–3587. 279 indexed citations
14.
Wright, Clifford D., Andrew M. Havill, Scot Middleton, et al.. (1999). Secretory Leukocyte Protease Inhibitor Prevents Allergen-Induced Pulmonary Responses in Animal Models of Asthma. Journal of Pharmacology and Experimental Therapeutics. 289(2). 1007–1014. 45 indexed citations
15.
16.
Lee, Patrice A., et al.. (1993). Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Critical Care Medicine. 21(6). 914–924. 86 indexed citations
17.
Lee, Patrice A., et al.. (1988). Cyanide-related changes in cerebral O2 delivery and metabolism in fluorocarbon-circulated rats. Toxicology and Applied Pharmacology. 94(1). 34–44. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elin Mortensen Breakdown of academic impact, for papers by Henrik Einwächter Breakdown of academic impact, for papers by Zibo Meng Breakdown of academic impact, for papers by Masaki Mizumoto Breakdown of academic impact, for papers by Marek Nowak Breakdown of academic impact, for papers by Nancy A. Turner Breakdown of academic impact, for papers by Stefan Liebe Breakdown of academic impact, for papers by Thomas Robert Breakdown of academic impact, for papers by Elena Magni Breakdown of academic impact, for papers by Jun Xue
Rankless by CCL
2026